相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
Jeffrey C. Weinreb et al.
RADIOLOGY (2021)
Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
Matthew S. Davenport et al.
RADIOLOGY (2020)
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent A Systematic Review and Meta-analysis
Sean A. Woolen et al.
JAMA INTERNAL MEDICINE (2020)
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis
Nicola Schieda et al.
RADIOLOGY (2020)
Risk of Nephrogenic Systemic Fibrosis from Gadoxetic Acid in Patients with Severe Kidney Disease
Matthew S. Davenport et al.
RADIOLOGY (2020)
Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium based Contrast Agent Administration: Subanalysis by Cironic Kidney Disease Stage
Prasad R. Shankar et al.
RADIOLOGY (2020)
Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists
Nicola Schieda et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2019)
A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis
Hanieh Attari et al.
RADIOLOGY (2019)
Virtual Elimination of Nephrogenic Systemic Fibrosis: A Medical Success Story with a Small Asterisk
Matthew S. Davenport
RADIOLOGY (2019)
Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Nicola Schieda et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2018)
Gadobutrol in Renally Impaired Patients Results of the GRIP Study
Henrik J. Michaely et al.
INVESTIGATIVE RADIOLOGY (2017)
Gadolinium-based contrast agents: A comprehensive risk assessment
Tyler J. Fraum et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates
Robert J. McDonald et al.
RADIOLOGY (2017)
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House
Jerry Yee
ADVANCES IN CHRONIC KIDNEY DISEASE (2017)
MRI contrast agents: Classification and application (Review)
Yu-Dong Xiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Nephrogenic Systemic Fibrosis Risk After Liver Magnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal Impairment Results of a Prospective, Open-Label, Multicenter Study
Thomas Lauenstein et al.
INVESTIGATIVE RADIOLOGY (2015)
Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents
Emmanuil Smorodinsky et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report
Beatrice Nardone et al.
PEDIATRIC RADIOLOGY (2014)
Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
Ali K. Abu-Alfa
ADVANCES IN CHRONIC KIDNEY DISEASE (2011)
Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis
Kevin N. Christensen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Nephrogenic systemic fibrosis: Clinicopathological definition and workup recommendations
Michael Girardi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Nephrogenic Systemic Fibrosis Review of 370 Biopsy-Confirmed Cases
Zhitong Zou et al.
JACC-CARDIOVASCULAR IMAGING (2011)
Validation of the revised Schwartz estimating equation in a predominantly non-CKD population
Amy Staples et al.
PEDIATRIC NEPHROLOGY (2010)
Nephrogenic Systemic Fibrosis in Liver Disease: A Systematic Review
Sameer M. Mazhar et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Risk Factors for NSF: A Literature Review
Martin R. Prince et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy-Report from Two US Universities
Ersan Altun et al.
RADIOLOGY (2009)
Nephrogenic systemic fibrosis: A report of 29 cases
Wael M. Shabana et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue
Clark D. Wiginton et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Risk of nephrogenic systemic fibrosis: Evaluation of gadolinium chelate contrast agents at four American universities
Rebecca Wertman et al.
RADIOLOGY (2008)
Incidence of nephrogenic systemic fibrosis at two large medical centers
Martin R. Prince et al.
RADIOLOGY (2008)
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure
Jennifer B. Othersen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort
Tara Anne Collidge et al.
RADIOLOGY (2007)
Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: In vitro study
Marc C. Heinrich et al.
RADIOLOGY (2007)
Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
Peter Marckmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
T Grobner
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
The safety of gadolinium in patients with stage 3 and 4 renal failure
I Ergün et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency
AD Sam et al.
JOURNAL OF VASCULAR SURGERY (2003)
Safety of gadolinium contrast agent in hemodialysis patients
S Okada et al.
ACTA RADIOLOGICA (2001)
分享论文
